Akers Biosciences, Inc.

129 articles about Akers Biosciences, Inc.

• Akers Biosciences Announces Conference Call To Discuss Q1 2017 Earnings

  5/16/2017

• Akers Biosciences Updates On Akers Wellness Tests

  4/25/2017

• Akers Biosciences Reports Earnings For Fiscal Year 2016

  4/12/2017

• Akers Biosciences To Commercialize Heparin PF4 Rapid Test In Puerto Rico

  4/10/2017

• Akers Biosciences Announces Conference Call To Discuss FY 2016 Earnings

  4/10/2017

• Akers Biosciences Reports Preliminary Unaudited Earnings Highlights For Fiscal Year 2016

  3/31/2017

• Akers Biosciences Announces A $2 Million Private Placement

  3/31/2017

• Akers Biosciences Begins Selling Rapid Cholesterol Test Through Distribution Agreement With First Check

  3/29/2017

• Akers Biosciences Allowed US Patent For Akers Wellness Tests Cartridge

  2/16/2017

• Akers Biosciences: Biotech Announces Closing Of Public Offering

  1/16/2017

• Akers Biosciences Release: Company Announces Pricing Of Public Offering Of 1,667,000 Shares And 833,500 Warrants

  1/10/2017

• Akers Biosciences Signs 3-year Agreement With GNYHA Services For Heparin PF4 Rapid Test

  12/22/2016

• Akers Biosciences Signs 3-year Agreement With Greater New York Hospital Association For Heparin PF4 Rapid Test

  12/19/2016

• Akers Biosciences Signs Distribution Agreement With First Check Diagnostics For Rapid Cholesterol Test

  12/1/2016

• Akers Biosciences Completes Clinical Trial For Rapid Diabetic Ketoacidosis Breath Test

  11/28/2016

• Akers Biosciences Announces Q3 Earnings

  11/14/2016

• Akers Biosciences Issued European Patent Protection For Breath Ketone Detector

  11/11/2016

• Akers Biosciences Completes Study On First Rapid Breath Test For Oxidative Stress

  8/19/2016

• Akers Biosciences Announces H1 And Q2 2016 Earnings

  8/11/2016

• Akers Biosciences Announces Conference Call to Discuss Q2 2016 Earnings

  8/10/2016